Lars Lannfelt

4PUBLICATIONS
34CO-AUTHORS
Automotive safety engineeringNanofabrication, growth and self assemblyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 31, 2026
The Uppsala APP Mutation Promotes Wild-Type Amyloid-β Aggregation and Deposition In Vivo.

Junyue Ge, María Pagnon de la Vega, Silvia Zampar

|Mar 10, 2025
Endogenously generated Dutch-type Aβ nonfibrillar aggregates dysregulate presynaptic neurotransmission in the absence of detectable inflammation.

Emilie L Castranio, Merina Varghese, Elentina K Argyrousi

|Dec 12, 2023
A light at the end of the tunnel - from mutation identification to a potential treatment for Alzheimer's disease.

Lars Lannfelt

|Oct 17, 2022
Lecanemab, Aducanumab, and Gantenerumab - Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease.

Linda Söderberg, Malin Johannesson, Patrik Nygren

Pageof 1

Frequent Collaborators

1 joint publications

Emilie L Castranio

1 joint publications

Merina Varghese

1 joint publications

Elentina K Argyrousi

1 joint publications

Kuldeep Tripathi